Spark Investment Management’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Spark Investment Management's KITE Position: Q4 2017 in Review
Spark Investment Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 53,300 shares — an estimated $9.58M sold.
Spark Investment Management first reported a position in KITE in Q2 2017 and held it in 2 quarters. The position peaked at $9.58M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Spark Investment Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Spark Investment Management sold 53,300 Kite Pharma, Inc. shares in Q4 2017, an estimated $9.58M.
- Spark Investment Management first reported a position in Kite Pharma, Inc. in Q2 2017 and held it in 2 quarters.
- Spark Investment Management's Kite Pharma, Inc. position peaked at $9.58M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Spark Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.